Lung Cancer
A Parallel Phase 2 Study of Glesatinib, Sitravatinib or Mocetinostat in Combination With Nivolumab in Advanced or Metastatic Non-Small Cell Lung Cancer (MRTX-500)
- Details
ClinicalTrials.gov ID:
NCT02954991
Diagnosis Type:
NSCLC
USOR Number:
- Address
11750 W 2nd Place, Suite 160
Lakewood, CO 80228
P: (303) 430-2700